Correlation analysis of invasive disease-free survival and overall survival in a real-world population of patients with HR+/HER2- early breast cancer.
Saved in:
| Title: | Correlation analysis of invasive disease-free survival and overall survival in a real-world population of patients with HR+/HER2- early breast cancer. |
|---|---|
| Authors: | Graff SL; Brown University Health Cancer Institute, Legorreta Cancer Center at Brown University, Providence, Rhode Island, USA., Tolaney SM; Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Hart LL; Florida Cancer Specialists, Sarah Cannon Research Institute, Fort Myers, Florida, USA.; Wake Forest University School of Medicine, Winston-Salem, North Carolina, USA., Razavi P; Memorial Sloan Kettering Cancer Center, New York, New York, USA., Janni W; Department of Gynecology and Obstetrics, University Hospital Ulm, Ulm, Germany., Schwartzberg LS; Renown Health-William N. Pennington Cancer Institute, Reno, Nevada, USA., Danyliv A; Novartis Pharma AG, Basel, Switzerland., Akdere M; Novartis Pharma AG, Basel, Switzerland., Ferrusi I; Novartis Pharmaceuticals Corporation, East Hanover, New Jersey, USA., Adhikary RR; Novartis Healthcare Pvt., Ltd, Hyderabad, Telangana, India., O'Shaughnessy JA; Texas Oncology/Baylor University Medical Center, Dallas, Texas, USA. |
| Source: | Cancer [Cancer] 2025 Apr 01; Vol. 131 (7), pp. e35817. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Wiley Country of Publication: United States NLM ID: 0374236 Publication Model: Print Cited Medium: Internet ISSN: 1097-0142 (Electronic) Linking ISSN: 0008543X NLM ISO Abbreviation: Cancer Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1097-0142 |
|---|---|
| DOI: | 10.1002/cncr.35817 |
